Compare ALVO & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | SAFE |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | Luxembourg | United States |
| Employees | 1032 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 1999 |
| Metric | ALVO | SAFE |
|---|---|---|
| Price | $3.62 | $13.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 11 |
| Target Price | $8.00 | ★ $18.82 |
| AVG Volume (30 Days) | ★ 605.3K | 245.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.28% |
| EPS Growth | N/A | ★ 7.43 |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | ★ $385,552,000.00 |
| Revenue This Year | $37.82 | N/A |
| Revenue Next Year | $25.80 | $4.31 |
| P/E Ratio | $18.20 | ★ $8.44 |
| Revenue Growth | N/A | ★ 5.43 |
| 52 Week Low | $3.03 | $12.76 |
| 52 Week High | $11.85 | $18.16 |
| Indicator | ALVO | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 47.47 | 33.45 |
| Support Level | $3.03 | $12.87 |
| Resistance Level | $4.17 | $14.29 |
| Average True Range (ATR) | 0.19 | 0.39 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 70.00 | 19.31 |
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.